Market Research Logo

European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), by Application (Oncology, Thyroid, Cardiology) - Forecasts to 2020

European Nuclear Medicine/Radiopharmaceuticals Market by Type (Diagnostic (SPECT - Technetium, PET - F-18), Therapeutic (Beta Emitters - I-131, Alpha Emitters, Brachytherapy - Y-90)), by Application (Oncology, Thyroid, Cardiology) - Forecasts to 2020

The European nuclear medicine/radiopharmaceuticals market is segmented on the basis of type, application, and country. The European nuclear medicine/radiopharmaceuticals market is valued at USD 1.095 billion in 2015 and is poised to grow at a CAGR of 8.2% during the forecasted period.

Factors such as increasing preference for SPECT and PET scans, advances in radiotracers, advent of alpha radio immunotherapy-based targeted cancer treatment, increasing incidence & mortality rate of cancer and cardiac ailments are driving the growth of this market. Moreover, potential radioisotopes in the pipeline, cyclotron based production are likely to create huge opportunities for this market in the coming years. However, factors such as shorter half-life of radiopharmaceuticals, competition from conventional diagnostic procedures are hindering the growth of this market.

Some of the major players in the European nuclear medicine/radiopharmaceuticals market include Cardinal Health Inc. (U.S.), GE Healthcare (U.K.), Bracco Imaging S.p.A (Italy), Eczacibasi-Monrol Nuclear Products (Turkey), Nordion, Inc. (Canada), Advanced Accelerator Applications S.A. (France), Bayer Healthcare (Germany), Lantheus Medical Imaging, Inc. (U.S.), IBA Molecular Imaging (Belgium), and Mallinckrodt plc (Ireland).

Reasons to Buy the Report:

The report will enrich both established firms as well as new entrants/smaller firms to gauge the pulse of the European market, which in turn helps the firms garner a greater market share. Firms purchasing the report could use any one or a combination of the below-mentioned five strategies (market penetration, product development/innovation, market development, market diversification, and competitive assessment) for strengthening their market shares.

The report provides insights on the following pointers:

Market Penetration: Comprehensive information on the product portfolios offered by the top players in the European nuclear medicine/radiopharmaceuticals market. The report analyzes the European nuclear medicine/radiopharmaceuticals market by type, application, and country

Product Development/Innovation: Detailed insights on the upcoming technologies, research and development activities, and new product launches in the European nuclear medicine/radiopharmaceuticals market

Market Development: Comprehensive information about the lucrative emerging markets. The report analyzes the markets for various European nuclear medicine/radiopharmaceuticals technologies across Europe

Market Diversification: Exhaustive information about new products, untapped regions, recent developments, and investments in the European nuclear medicine/radiopharmaceuticals market

Competitive Assessment: In-depth assessment of the market shares, strategies, products, distribution networks, and manufacturing capabilities of the leading players in the European nuclear medicine/radiopharmaceuticals market


  • INTRODUCTION
    • OBJECTIVES OF STUDY
    • MARKET DEFINITION
    • MARKET SCOPE
      • MARKETS COVERED
      • YEARS CONSIDERED FOR THE STUDY
    • CURRENCY
    • LIMITATIONS
    • STAKEHOLDERS
  • RESEARCH METHODOLOGY
    • RESEARCH METHODOLOGY STEPS
    • SECONDARY AND PRIMARY RESEARCH METHODOLOGY
      • SECONDARY RESEARCH
      • PRIMARY RESEARCH
      • KEY INDUSTRY INSIGHTS
    • KEY DATA FROM PRIMARY SOURCES
    • KEY INSIGHTS FROM PRIMARY SOURCES
    • MARKET SIZE ESTIMATION METHODOLOGY
    • RESEARCH DESIGN
    • MARKET DATA VALIDATION AND TRIANGULATION
    • ASSUMPTIONS FOR THE STUDY
  • EXECUTIVE SUMMARY
    • INTRODUCTION
    • CURRENT SCENARIO
    • FUTURE OUTLOOK
  • PREMIUM INSIGHTS
    • EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET
    • SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC MARKET, BY COUNTRY AND APPLICATION
    • EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY COUNTRY
    • EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY TYPE (2015 VS. 2020)
  • MARKET OVERVIEW
    • INTRODUCTION
    • MARKET DYNAMICS
      • DRIVERS
        • Table ALPHA RADIO IMMUNOTHERAPY-BASED TARGETED CANCER TREATMENT TO BOOST THE GROWTH OF THE EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET
      • RESTRAINTS
        • Table SHORTER HALF-LIFE OF RADIOPHARMACEUTICALS RESTRAINING THE GROWTH OF THE EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET
      • OPPORTUNITIES
        • Table POTENTIAL RADIOISOTOPES IN THE PIPELINE OFFER SIGNIFICANT GROWTH OPPORTUNITIES FOR THE EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET
      • CHALLENGE
        • Table SHUTDOWN OF NUCLEAR REACTORS IS A MAJOR CHALLENGE IN THE EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET
      • BURNING ISSUE
        • Table LOW HEALTHCARE SPENDING IN EUROPE IS A MAJOR BURNING ISSUE IN THE EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET
    • REGULATORY SCENARIO
      • INTRODUCTION
      • GERMANY
      • FRANCE
      • U.K.
      • SPAIN
      • ITALY
      • RUSSIA
      • SWITZERLAND
  • EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, PIPELINE ASSESSMENT
    • INTRODUCTION
    • DIAGNOSTIC RADIOISOTOPES
      • Table DETAILS OF RADIOPHARMACEUTICALS FOR UPCOMING DIAGNOSTIC APPLICATIONS
      • F-18
    • THERAPEUTIC RADIOISOTOPES
      • Table DETAILS OF RADIOPHARMACEUTICALS FOR UPCOMING THERAPEUTIC APPLICATIONS
      • RA-223
      • LU-177
  • EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY TYPE
    • INTRODUCTION
      • Table EUROPE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
    • DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS
      • Table EUROPE: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table EUROPE: DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • SPECT RADIOPHARMACEUTICALS
        • Table EUROPE: SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: SPECT NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2013-2020 (USD MILLION)
        • Table EUROPE: TECHNETIUM-99M MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: THALLIUM-201 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: GALLIUM-67 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: IODINE-123 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: OTHER SPECT ISOTOPES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • PET RADIOPHARMACEUTICALS
        • Table EUROPE: PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: PET NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY ISOTOPE TYPE, 2013-2020 (USD MILLION)
        • Table EUROPE: FLUORINE-18 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: RUBIDIUM-82 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: OTHER PET ISOTOPES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS
      • Table EUROPE: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table EUROPE: THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • BETA EMITTERS
        • Table EUROPE: BETA EMITTERS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: BETA EMITTERS MARKET SIZE, BY ISOTOPE TYPE, 2013-2020 (USD MILLION)
        • Table EUROPE: IODINE-131 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: YTTRIUM-90 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: SAMARIUM-153 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: RHENIUM-186 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: LUTETIUM-177 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: OTHER BETA EMITTER ISOTOPES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • ALPHA EMITTERS
        • Table EUROPE: ALPHA EMITTERS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
      • BRACHYTHERAPY
        • Table EUROPE: BRACHYTHERAPY ISOTOPES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: BRACHYTHERAPY ISOTOPES MARKET SIZE, BY ISOTOPE TYPE, 2013-2020 (USD MILLION)
        • Table EUROPE: IODINE-125 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: IRIDIUM-192 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: PALLADIUM-103 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: CESIUM-131 MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table EUROPE: OTHER BRACHYTHERAPY ISOTOPES MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
  • EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY APPLICATION
    • INTRODUCTION
    • DIAGNOSTIC APPLICATIONS
      • SPECT APPLICATIONS
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR CARDIOLOGY SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR LYMPHOMA SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR NEUROLOGY SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR THYROID SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR OTHER SPECT APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • PET APPLICATIONS
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR ONCOLOGY PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR CARDIOLOGY PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR NEUROLOGY PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR OTHER PET APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
    • THERAPEUTIC APPLICATIONS
      • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR THERAPEUTIC APPLICATIONS, BY TYPE, 2013-2020 (USD MILLION)
      • THYROID
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR THYROID THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • BONE METASTASIS
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BONE METASTASIS THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • LYMPHOMA
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR LYMPHOMA THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • ENDOCRINE TUMORS
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR ENDOCRINE THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
      • OTHER THERAPEUTIC APPLICATIONS
        • Table NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR OTHER THERAPEUTIC APPLICATIONS, BY COUNTRY, 2013-2020 (USD MILLION)
  • EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS, PROCEDURAL VOLUME
    • INTRODUCTION
      • Table EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND)
      • Table EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS PROCEDURAL VOLUME, BY COUNTRY, 2013-2020 (THOUSAND)
    • EUROPEAN DIAGNOSTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS PROCEDURAL VOLUME
      • Table EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND)
      • SPECT RADIOPHARMACEUTICALS
        • Table EUROPEAN NUCLEAR MEDICINE PROCEDURAL VOLUME FOR SPECT RADIOPHARMACEUTICALS, BY TYPE, 2013-2020 (THOUSAND)
      • PET RADIOPHARMACEUTICALS
        • Table EUROPEAN NUCLEAR MEDICINE PROCEDURAL VOLUME FOR PET RADIOPHARMACEUTICALS, BY TYPE, 2013-2020 (THOUSAND)
    • EUROPEAN THERAPEUTIC NUCLEAR MEDICINE/RADIOPHARMACEUTICALS PROCEDURAL VOLUME
      • Table EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC PROCEDURAL VOLUME, BY TYPE, 2013-2020 (THOUSAND)
      • BETA EMITTERS
        • Table EUROPEAN NUCLEAR MEDICINE PROCEDURAL VOLUME FOR BETA EMITTERS, BY TYPE, 2013-2020 (THOUSAND)
      • ALPHA EMITTERS
        • Table EUROPEAN NUCLEAR MEDICINE PROCEDURAL VOLUME FOR ALPHA EMITTERS, BY TYPE, 2013-2020 (THOUSAND)
      • BRACHYTHERAPY
        • Table EUROPEAN NUCLEAR MEDICINE PROCEDURAL VOLUME FOR BRACHYTHERAPY, BY TYPE, 2013-2020 (THOUSAND)
  • EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET, BY COUNTRY/REGION
    • INTRODUCTION
      • Table EUROPEAN NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY COUNTRY, 2013-2020 (USD MILLION)
    • GERMANY
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY TYPE, 2013-2020 (USD MILLION)
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BETA EMITTERS, BY TYPE, 2013-2020 (USD MILLION)
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BRACHYTHERAPY, BY TYPE, 2013-2020 (USD MILLION)
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table GERMANY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
    • FRANCE
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY TYPE, 2013-2020 (USD MILLION)
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BETA EMITTERS, BY TYPE, 2013-2020 (USD MILLION)
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BRACHYTHERAPY, BY TYPE, 2013-2020 (USD MILLION)
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table FRANCE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
    • ITALY
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY TYPE, 2013-2020 (USD MILLION)
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BETA EMITTERS, BY TYPE, 2013-2020 (USD MILLION)
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BRACHYTHERAPY, BY TYPE, 2013-2020 (USD MILLION)
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table ITALY: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
    • U.K.
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY TYPE, 2013-2020 (USD MILLION)
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BETA EMITTERS, BY TYPE, 2013-2020 (USD MILLION)
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BRACHYTHERAPY, BY TYPE, 2013-2020 (USD MILLION)
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table U.K.: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
    • SPAIN
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY TYPE, 2013-2020 (USD MILLION)
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BETA EMITTERS, BY TYPE, 2013-2020 (USD MILLION)
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BRACHYTHERAPY, BY TYPE, 2013-2020 (USD MILLION)
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table SPAIN: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
    • RUSSIA
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY TYPE, 2013-2020 (USD MILLION)
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BETA EMITTERS, BY TYPE, 2013-2020 (USD MILLION)
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BRACHYTHERAPY, BY TYPE, 2013-2020 (USD MILLION)
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table RUSSIA: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
    • REST OF EUROPE (ROE)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS DIAGNOSTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY TYPE, 2013-2020 (USD MILLION)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY TYPE, 2013-2020 (USD MILLION)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY TYPE, 2013-2020 (USD MILLION)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BETA EMITTERS, BY TYPE, 2013-2020 (USD MILLION)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR BRACHYTHERAPY, BY TYPE, 2013-2020 (USD MILLION)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR SPECT, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS MARKET SIZE FOR PET, BY APPLICATION, 2013-2020 (USD MILLION)
      • Table ROE: NUCLEAR MEDICINE/RADIOPHARMACEUTICALS THERAPEUTIC MARKET SIZE, BY APPLICATION, 2013-2020 (USD MILLION)
  • COMPETITIVE LANDSCAPE
    • OVERVIEW
    • COMPETITIVE SITUATION AND TRENDS
      • INTRODUCTION
      • AGREEMENTS & CONTRACTS
        • Table AGREEMENTS & CONTRACTS, 2012-2015
      • ACQUISITIONS
        • Table ACQUISITIONS, 2012-2015
      • MARKET DEVELOPMENTS
        • Table MARKET DEVELOPMENTS, 2012-2015
      • EXPANSIONS
        • Table EXPANSIONS, 2012-2015
      • OTHER STRATEGIES
        • Table OTHER STRATEGIES, 2012-2015
  • COMPANY PROFILES
    • CARDINAL HEALTH, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • MALLINCKRODT PLC
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • GE HEALTHCARE
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • LANTHEUS MEDICAL IMAGING, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BAYER HEALTHCARE
      • BUSINESS OVERVIEW
      • PRODUCT OFFERED
      • RECENT DEVELOPMENTS
      • MNM VIEW
    • BRACCO IMAGING S.P.A
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ECZACIBASI-MONROL NUCLEAR PRODUCTS
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • NORDION, INC.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • ADVANCED ACCELERATOR APPLICATIONS S.A.
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
    • IBA MOLECULAR IMAGING
      • BUSINESS OVERVIEW
      • PRODUCTS OFFERED
      • RECENT DEVELOPMENTS
  • APPENDIX
    • DISCUSSION GUIDE
    • AVAILABLE CUSTOMIZATIONS
    • INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
    • RELATED REPORTS

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report